Several clinical studies have clearly demonstrated that GDF-15 was a strong biomarker of cardiovascular disease, and a prognosis marker of fatal events in patients with myocardial infarction[7], [8], [30] and chronic HF[9], [15]. This evidence concerns the gene GDF15 and myocardial infarction.